New $195 million facility will further enhance AbbVie's active pharmaceutical ingredient (API) production capacity and capabilities in the U.S.Expansion is part of AbbVie's previously announced commitment...
HOPEWELL, N.J., Aug. 11, 2025 /PRNewswire/ -- ProBio, a leading contract development and manufacturing organization (CDMO) specializing in gene and cell therapy, today announced...
Stephen to lead company-wide execution, strengthening AST's Executive Leadership Team
TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ -- AST is pleased to announce that Jacob Stephen will...
WUXI, China, Aug. 4, 2025 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing...
Industry veteran joins Solvias to lead U.S. expansion and strengthen delivery of advanced analytical solutions for biopharma clients.
KAISERAUGST, Switzerland, Aug. 4, 2025 /PRNewswire/ --...
Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of...
MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise.
A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra® for men - in a proprietary topical formulation demonstrated to work where women need it most
The Conference Forum announces the 15th annual PODD Drug Delivery Conference's 2025 agenda and featured sessions.
NEW YORK, July 16, 2025 /PRNewswire/ -- Today, PODD: Partnership...
PRINCETON, N.J. and HOUSTON, July 15, 2025 /PRNewswire/ -- Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Sentinel...